Corey McCann

Bio

Dr. Corey M McCann joins MPM's Boston office as a Principal. Prior to MPM, he was an Engagement Manager with McKinsey & Company, where he advised pharmaceutical, medical device, and biotechnology companies on the acquisition, development, and commercialization of life science technologies. In addition, he was a leader of McKinsey's Central Nervous System (CNS) expertise group, advising clients across the healthcare value chain. Dr. McCann brings investment experience to MPM. He was previously an Associate with RiverVest Venture Partners where he performed diligence on early stage investments and he was also a Market Analyst for NeuroInsights, covering advances in brain related technologies. He is a co-founder of Alcyone Lifesciences, a startup focused on developing treatments for chronic neurologic conditions. Dr. McCann trained as a physician-scientist via the Medical Scientist Training Program. For his Ph.D., he studied the molecular biology of synapses at Harvard University and Washington University in St Louis. He was also a researcher at the Massachusetts General Hospital where he developed imaging techniques for the visualization of the brain. Dr. McCann received his M.D. from Washington University in St. Louis. He graduated summa cum laude from The Pennsylvania State University where he was an Evan Pugh Scholar, receiving a B.S. in Biology with minors in neuroscience, biochemistry, and molecular biology.